SCHEMBL9369634

SCHEMBL9369634

CC(Sc1nccn1-c1cn[nH]c1)N(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NR4A1 P22736 1/20 0.30
▸ NR4A2 P43354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10775575 0.75 NOS2 (0.33) —
SCHEMBL9369639 0.75 L3MBTL1 (0.41) —
SCHEMBL9369801 0.73 FGFR1 (0.35) NR4A1NR4A2
SCHEMBL9369497 0.69 CHRNB2 (0.31) —
SCHEMBL9369105 0.69 RPS6KA5 (0.38) —
SCHEMBL9371807 0.68 FGFR1 (0.35) —
SCHEMBL9369020 0.68 ADORA2B (0.33) —
SCHEMBL369552 0.66 PLK1 (0.31) —
SCHEMBL9012028 0.61 L3MBTL1 (0.47) NR4A1NR4A2
SCHEMBL11459475 0.59 NR4A1 (0.47) NR4A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244803-B1 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMA (US) 1994-10-26 — — EP disclosed
EP-0244803-A2 Novel dopamine beta hydroxylase inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1987-11-11 — — EP disclosed
Send feedback